Oral edaravone ameliorates myocardial fibrosis in diabetic rats by TGF-beta1/Smad signaling pathway
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
Myocardial fibrosis, characterized by increased reactive oxygen species (ROS), is a key pathological feature of diabetic cardiomyopathy (DCM). Although oral edaravone (EDA) shows therapeutic potential in ameliorating myocardial fibrosis in DCM, the precise mechanisms remain unclear.
创建时间：
2025-09-30
